Callan Family Office’s Baker Hughes BKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.3M Sell
119,559
-3,770
-3% -$218K 0.17% 124
2025
Q4
$5.62M Buy
123,329
+7,784
+7% +$369K 0.12% 177
2025
Q3
$5.63M Sell
115,545
-4,655
-4% -$205K 0.18% 130
2025
Q2
$4.61M Buy
120,200
+82,359
+218% +$3.11M 0.15% 165
2025
Q1
$1.66M Buy
37,841
+6,309
+20% +$281K 0.12% 148
2024
Q4
$1.29M Buy
+31,532
New +$1.27M 0.08% 207
2023
Q2
Sell
-14,100
Closed -$407K 113
2023
Q1
$407K Buy
+14,100
New +$426K 0.1% 107

Other funds holding BKR

Callan Family Office's BKR Position: Q1 2026 in Review

Callan Family Office reduced its Baker Hughes (BKR) stake by 3.1% in Q1 2026, selling an estimated $218K and leaving 119,559 shares worth $7.3M. The position accounts for 0.17% of the portfolio, ranked #124.

Callan Family Office first reported a position in BKR in Q1 2023 and has held it in 7 quarters since. 1,149 funds tracked by Wall St. Rank hold BKR as of Q1 2026.

  • Callan Family Office held 119,559 shares of Baker Hughes worth $7.3M as of Q1 2026.
  • Callan Family Office sold 3,770 Baker Hughes shares in Q1 2026, an estimated $218K.
  • Baker Hughes made up 0.17% of Callan Family Office's portfolio in Q1 2026, its #124 holding.
  • Callan Family Office first reported a position in Baker Hughes in Q1 2023 and has held it in 7 quarters since.
  • 1,149 funds tracked by Wall St. Rank held Baker Hughes as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.